Active Ingredients (In Each Extended-Release Tablet)
Guaifenesin 600 mg
Pseudoephedrine HCl 60 mg
The following Structured Product Label (SPL) was submitted to the FDA by Cvs Woonsocket Prescription Center, Incorporated for the product Mucus D (NDC 51316-878). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredients (in each extended-release tablet), purposes, uses, do not use, ask a doctor before use if you have, when using this product, stop use and ask a doctor if, if pregnant or breast-feeding,, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Guaifenesin 600 mg
Pseudoephedrine HCl 60 mg
Expectorant
Nasal Decongestant
if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
carbomer homopolymer type B, colloidal silicon dioxide, FD&C yellow #6 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, sodium starch glycolate
1-800-719-9260
CVS™
12 HR
actual size
Extended-Release
MUCUS-D
Guaifenesin & Pseudoephedrine Hydrochloride
Extended-Release Tablets
600 mg / 60 mg
Expectorant, Nasal Decongestant
Compare to Mucinex® D active ingredients
Clears Nasal / Sinus Congestion
Thins & Loosens Mucus
Immediate & Extended Release
Relieves Nasal & Chest Congestion
18 EXTENDED-RELEASE TABLETS
* Please review the disclaimer below.